|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM375795073 |
| 003 |
DE-627 |
| 005 |
20250306115627.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240802s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.bej.2024.109418
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1251.xml
|
| 035 |
|
|
|a (DE-627)NLM375795073
|
| 035 |
|
|
|a (NLM)39092080
|
| 035 |
|
|
|a (PII)109418
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wu, Meishan
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Evaluation of the efficiency of various methods to load fluoroquinolones into Escherichia coli outer membrane vesicles as a novel antibiotic delivery platform
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 06.08.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a The development of novel antibacterial agents that are effective against Gram-negative bacteria is limited primarily by transport issues. This class of bacteria maintains a complex cell envelope consisting of two membrane bilayers, preventing the passage of most antibiotics. These drugs must therefore pass through protein channels called porins; however, many antibiotics are too large to pass through porins, and a common mechanism of acquired resistance is down-regulation of porins. To overcome this transport limitation, we have proposed the use of outer membrane vesicles (OMVs), released by Gram-negative bacteria, which deliver cargo to other bacterial cells in a porin-independent manner. In this work, we systematically studied the ability to load fluoroquinolones into purified Escherichia coli OMVs using in vivo and in vitro passive loading methods, and active loading methods such as electroporation and sonication. We observed limited loading of all of the antibiotics using passive loading techniques; sonication and electroporation significantly increased the loading, with electroporation at low voltages (200 and 400V) resulting in the greatest encapsulation efficiencies. We also demonstrated that imipenem, a carbapenem antibiotic, can be readily loaded into OMVs, and its administration via OMVs increases the effectiveness of the drug against E. coli. Our results demonstrate that small molecule antibiotics can be readily incorporated into OMVs to create novel delivery vehicles to improve antibiotic activity
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Gram-negative bacteria
|
| 650 |
|
4 |
|a Outer membrane vesicles
|
| 650 |
|
4 |
|a antibiotic resistance
|
| 650 |
|
4 |
|a fluoroquinolones
|
| 700 |
1 |
|
|a Holgado, Lauryn
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Harrower, Rachael M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Brown, Angela C
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Biochemical engineering journal
|d 1998
|g 210(2024) vom: 01. Okt.
|w (DE-627)NLM098270710
|x 1369-703X
|7 nnas
|
| 773 |
1 |
8 |
|g volume:210
|g year:2024
|g day:01
|g month:10
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.bej.2024.109418
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 210
|j 2024
|b 01
|c 10
|